Covid 19 associated black fungus of nose and eyes
Not Applicable
- Conditions
- Health Condition 1: B461- Rhinocerebral mucormycosis
- Registration Number
- CTRI/2021/06/034337
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Any patient above 18 years of age with following complaints
Nasal blockade or congestion, nasal discharge (bloody or brown/black), local pain
Pain, numbness or swelling of facial skin
Headache or blurred or double vision withpainin
Toothache, loosening of maxillary teeth, jaw involvement
2. COVID -19 positive on nasopharyngeal RT-PCR or Chest CT suggestive of COVID-19 less than 2 months old with mucormycosis confirmed on histopathology.
Both criteria 1 and 2 must be met for inclusion in the study.
Exclusion Criteria
Mucormycosis cases without a confirmed bout of preceding COVID-19
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify the risk factors in causation of mucormycosis in COVID -19 patients.Timepoint: at baseline
- Secondary Outcome Measures
Name Time Method To study the demographic profile and presenting features of mucormycosis following COVID-19 during the second waveTimepoint: at the time of baseline